Profile data is unavailable for this security.
About the company
Evolva Holding Ltd is a Switzerland-based Company operating as a researcher for biotechnology. The Company develops and commercializes nature-based ingredients. The ingredients, produced by the Company, can be employed in, but not limited to, flavorings fragrancies, health ingredients, health protection and other various sectors. The objectives of the Company are as follows: develop technology platforms - combines biology with technology to produce nature-based ingredients; provide technology services- provides tailored services to clients across industries. The Company is focused on developing and increasing the return and effectiveness of the production of numerous ingredients within their portfolio.
- Revenue in CHF (TTM)4.16m
- Net income in CHF-101.22m
- Incorporated1997
- Employees49.00
- LocationEvolva Holding LtdDuggingerstrasse 23REINACH 4153SwitzerlandCHE
- Phone+41 614852000
- Fax+41 614852001
- Websitehttps://www.evolva.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Double Bond Phrmcutcl Intrntnl AB (publ) | 116.28k | -1.47m | 6.14m | 10.00 | -- | 12.88 | -- | 52.79 | -0.1837 | -0.1837 | 0.0136 | 0.0556 | 0.1016 | -- | 18.59 | 137,033.00 | -128.49 | -80.90 | -198.98 | -106.45 | -241.22 | -686.41 | -1,265.24 | -1,360.03 | -- | -217.55 | 0.00 | -- | 10.25 | 135.07 | -14.36 | -- | -- | -- |
| ExpreS2ion Biotech Holding AB | 746.63k | -7.76m | 6.14m | 26.00 | -- | 1.11 | -- | 8.23 | -2.00 | -2.00 | 0.1833 | 1.27 | 0.0815 | -- | 9.91 | 338,423.10 | -84.61 | -63.54 | -105.52 | -75.88 | -109.74 | -1.94 | -1,038.77 | -524.31 | -- | -- | 0.0042 | -- | 43.07 | -0.1561 | 22.94 | -- | 19.90 | -- |
| Abera Bioscience AB | 0.00 | -1.42m | 6.25m | -- | -- | 12.27 | -- | -- | -1.24 | -1.24 | 0.00 | 0.391 | 0.00 | -- | -- | -- | -115.63 | -79.43 | -149.06 | -96.11 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 13.73 | -- | -- | -- |
| Chosa Oncology AB | 6.19k | -2.03m | 6.38m | -- | -- | 3.95 | -- | 1,030.15 | -0.3524 | -0.3524 | 0.0013 | 0.2684 | 0.003 | -- | 0.013 | -- | -96.68 | -51.96 | -178.66 | -61.92 | -- | -- | -32,798.63 | -708.47 | -- | -97.97 | -- | -- | -98.21 | -- | 28.33 | -- | -- | -- |
| Coegin Pharma AB | 0.00 | -2.37m | 6.73m | 0.00 | -- | 6.09 | -- | -- | -2.65 | -2.65 | 0.00 | 0.6403 | 0.00 | -- | -- | -- | -125.24 | -122.02 | -201.53 | -154.70 | -- | -- | -- | -28,466.75 | -- | -170.65 | 0.00 | -- | -- | -- | 20.60 | -- | -- | -- |
| Dextech Medical AB | 0.00 | -384.17k | 6.81m | 1.00 | -- | 2.60 | -- | -- | -0.2449 | -0.2449 | 0.00 | 1.67 | -- | -- | -- | -- | -- | -28.96 | -- | -29.94 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 12.89 | -- | 0.412 | -- |
| Evolva Holding Ltd | 4.16m | -101.22m | 6.87m | 49.00 | -- | 1.23 | -- | 1.65 | -14.04 | -14.04 | 0.7083 | 0.77 | 0.0685 | -- | 1.91 | -- | -166.87 | -37.51 | -190.97 | -41.07 | -23.54 | -- | -2,434.99 | -818.05 | -- | 0.4155 | 0.00 | -- | 517.55 | -14.19 | -22.13 | -- | -- | -- |
| Biosergen AB | 0.00 | -2.29m | 6.99m | 3.00 | -- | 7.11 | -- | -- | -0.4007 | -0.4007 | 0.00 | 0.0418 | 0.00 | -- | -- | 0.00 | -131.31 | -- | -217.09 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 32.25 | -- | -- | -- |
| Sprint Bioscience AB | 5.80m | 744.25k | 7.35m | 36.00 | 9.87 | 3.50 | 9.28 | 1.27 | 0.1256 | 0.1256 | 0.9791 | 0.3538 | 1.58 | -- | 11.45 | 2,441,286.00 | 20.29 | -71.22 | 43.20 | -113.71 | 80.06 | 62.75 | 12.83 | -110.22 | -- | -- | 0.00 | -- | 60,725.30 | 22.99 | 99.27 | -- | -26.02 | -- |
| Friulchem SpA | 26.35m | -295.53k | 7.35m | 86.00 | -- | 0.5327 | 15.18 | 0.2791 | -0.0498 | -0.0498 | 4.44 | 1.75 | 0.7064 | 2.93 | 4.28 | -- | -0.9831 | -0.3406 | -1.82 | -0.5598 | 18.17 | 17.60 | -1.39 | -0.4058 | 0.6212 | 0.6976 | 0.5576 | -- | -22.20 | 10.62 | -992.27 | -- | -- | -- |
| Opticept Technologies AB | 775.99k | -6.82m | 7.66m | 29.00 | -- | 0.1981 | -- | 9.88 | -2.62 | -2.62 | 0.2981 | 10.80 | 0.0213 | -0.0638 | 2.37 | 315,344.80 | -18.69 | -41.76 | -21.19 | -46.21 | 125.88 | 62.65 | -879.63 | -882.41 | 0.6163 | -14.16 | 0.0566 | -- | -12.90 | 49.17 | 19.80 | -- | 45.22 | -- |
| Cizzle Biotechnology Holdings PLC | 0.00 | -1.98m | 7.67m | 67.00 | -- | 4.04 | -- | -- | -0.0048 | -0.0048 | 0.00 | 0.0041 | 0.00 | -- | -- | -- | -76.69 | -144.15 | -82.81 | -167.75 | -- | -- | -- | -- | -- | -0.805 | 0.00 | -- | -- | -- | -88.27 | -- | -- | -- |
| AroCell AB (publ) | 3.80m | -4.76m | 7.72m | -- | -- | 0.5942 | -- | 2.03 | -0.2437 | -0.2437 | 0.1944 | 0.6648 | 0.2325 | 5.82 | 5.63 | -- | -29.14 | -29.25 | -31.00 | -31.37 | 1.88 | -9.85 | -125.33 | -231.19 | 5.16 | -- | 0.00 | -- | 16.37 | 122.92 | -0.5494 | -- | -- | -- |
| Ziccum AB | 563.00k | -1.74m | 7.75m | 9.00 | -- | 6.96 | -- | 13.76 | -1.46 | -1.46 | 0.4721 | 0.8534 | 0.2696 | -- | 22.01 | 829,375.00 | -83.29 | -68.51 | -106.42 | -76.47 | -- | -- | -308.94 | -2,598.03 | -- | -- | 0.0516 | -- | -- | 75.20 | 25.62 | -- | -13.45 | -- |
Data as of May 17 2024. Currency figures normalised to Evolva Holding Ltd's reporting currency: Swiss Franc CHF
2.01%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Credit Suisse Asset Management (Schweiz) AGas of 29 Feb 2024 | 56.57k | 0.78% |
| UBS Asset Management Switzerland AGas of 07 May 2024 | 34.81k | 0.48% |
| Z�rcher Kantonalbank (Investment Management)as of 28 Mar 2024 | 31.34k | 0.43% |
| Credit Suisse AGas of 31 Jan 2024 | 7.22k | 0.10% |
| BlackRock Asset Management Schweiz AGas of 08 May 2024 | 6.96k | 0.10% |
| Picard Angst AGas of 30 Jun 2023 | 4.18k | 0.06% |
| DWS CH AGas of 28 Mar 2024 | 2.97k | 0.04% |
| Quorus Verm�gensverwaltung AGas of 27 Mar 2024 | 800.00 | 0.01% |
| State Street Global Advisors France SAas of 31 Mar 2024 | 476.00 | 0.01% |
| Migros Bank AGas of 31 Dec 2022 | 380.00 | 0.01% |
More ▼
Data from 30 Jun 2023 - 16 May 2024Source: FactSet Research Systems Inc.
